Skip to main content
SpringerLink
Log in

Calcium antagonists—Future uses

  • Editorial Comment
  • Focus On Calcium Modulation
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wagner JA, Snyder SII. Historical overview: From binding sites to channel opening (abstr). In: Fondazione G. Lorenzini.International Symposium on Calcium Antagonists. New York, 1987, p. 6.

  2. Hoffmeister F, Tettenborn D. Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-M-receptor agonists and neuropharmacological actions in rodents.Psychopharmacology 1986; 90:299–307.

    PubMed  Google Scholar 

  3. Fox KM, Krikler DM. Early treatment of unstable angina.Br Heart J 1986; 56:398–399.

    PubMed  Google Scholar 

  4. Braunwald E. Introduction: Calcium channel blockers.Am J Cardiol 1980; 46:1045.

    Article  PubMed  Google Scholar 

  5. Hugenholtz PG. Unstable angina pectoris. In: Krebs, R, ed.Treatment of Cardiovascular Diseases by Adalta (nifedipine). Stuttgart-New York: Schattaner, 1986; 187–229.

    Google Scholar 

  6. Muller JE, Namis Study Group: Nifedipine therapy for unstable angina and myocardial infarction: randomized double blind evaluations. In: Hugenholtz PG, Goldmans BS, ed.Unstable Angina, Current Concepts and Management. Stuttgart-New York: Schattaner, 1985; 199–210.

    Google Scholar 

  7. Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) research group: Early treatment of unstable angina in the coronary care unit: A randomized, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both.Br Heart J 1986; 56:400–413.

    Google Scholar 

  8. Yusuf S, Furberg C. Effect of acute or chronic administration of calcium antagonists on mortality following myocardial infarction.J Am Coll Cardiol 1987; 9:2417.

    Google Scholar 

  9. Simes PA,et al. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian nifedipine multicenter trial.Circulation 1984; 70:638–644.

    PubMed  Google Scholar 

  10. Gottlieb SO, Gerstenblith G, Shapiro EP,et al. Nifedipine reduces early infarct expansion: Results of a double-blind, randomized trial.

  11. Majid PA, Niznick J, Nishizaki S, Hag A. Hemodynamic effects of nifedipine in acute myocardial infarction with observations on infarct size.J Cardiovasc Pharmacol 1986; 8:262–267.

    PubMed  Google Scholar 

  12. Stone PH, Muller JE. Nifedipine therapy for recurrent ischemic pain following myocardial infarction.Clin Cardiol 1982; 5:223–230.

    PubMed  Google Scholar 

  13. Gibson RS. Diltiazem Reinfarction Study Group: Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction.N Engl J Med 1986; 315:423–429.

    PubMed  Google Scholar 

  14. Frishman WH. Calcium channel blockers for hypertensive emergencies.J Clin Hypertens 1986; 2:55–61.

    PubMed  Google Scholar 

  15. Kaltenbach M, Hopf R. Treatment of hypertrophic cardiomyopathy: Relation to pathological mechanisms.J Mol Cell Cardiol 1985; 17(Suppl 2):59–68.

    Article  PubMed  Google Scholar 

  16. Koide T, Kakihana M, Takabatake Y,et al. Long-term clinical effect of calcium inhibitors in hypertrophic cardiomyopathy compared to the effect of beta-blocking agents.Jpn Heart J 1981; 22:87–102.

    PubMed  Google Scholar 

  17. Betocchi S, Cannon RO, Watson RM,et al. Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.Circulation 1985; 72:1001–1007.

    PubMed  Google Scholar 

  18. Roine RO, Kaste M, Kinnunen A, Nikki P. Safety and efficacy of nimodipine in resuscitation of patients outside hospital.Br Med J 1987; 294:20.

    Google Scholar 

  19. Allen GS, Alm HS, Prezioso TJ,et al. A controlled trial of nimodipine in subarachnoid hemorrhage patients.N Engl J Med 1983; 308:619–624.

    PubMed  Google Scholar 

  20. Auer LM, Brandt L, Ebeling U,et al. Nimodipine and early aneurysm operation in good condition SAH patients.Acta Neurochir 1986; 82:7–13.

    Article  Google Scholar 

  21. Lunggreen B, Brandt L, Saeveland H,et al. Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine.J Neurosurg 1984; 61:864–873.

    PubMed  Google Scholar 

  22. Gelmess HJ, Gorter K, de Weerdt CJ, Wiezer HA. Efficacy of treatment with nimodipine (Calcium antagonist) in patients with acute ischemic stroke: A placebo-controlled, double-blind, randomized, multicenter trial.J Cereb Blood Flow Metab 1985; 5(Suppl 1):337–338.

    Google Scholar 

  23. Bormann RB, Boldt J, Sturm G,et al. Calciumantagonisten in der Analgesie. Additive Analgesie durch Nimodipine während cardiochirurgischer Eingriffe.Anaesthesist 1985; 34:429–434.

    PubMed  Google Scholar 

  24. Little HJ, Dolin SJ, Halsey MJ. Calcium channel antagonists decrease the ethanol withdrawal syndrome.Life Sci 1986; 39:2059–2065.

    Article  PubMed  Google Scholar 

  25. Kazda S, Scriabine A. Pharmacology. In: Krebs R, ed.Treatment of Cardiovascular Diseases by Adalat (Nifedipine). Stuttgart-New York: Schattaner, 1986; 43–92.

    Google Scholar 

  26. Henry P. Atherosclerosis, calcium, and calcium antagonists.Circulation 1985; 72:456–459.

    PubMed  Google Scholar 

  27. Sievens RE, Rashid T, Garret J,et al. Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits.Cardiovascular Drugs Ther 1987; 1:65–69.

    Google Scholar 

  28. Lichtlen PR, Nellessen U, Rafflenbeaul W. International nifedipine trial on anti-atherosclerotic therapy (INTACT): Study design and baseline values. In: Lichtlen PR, ed.Sixth International Adalat Symposium. Amsterdam-New York-Excerpta Medica, 1986; 462–470.

  29. Wagner K, Neumayer HH. Einfluss des calciumantagonisten Diltiazem auf das akute Nierenversagen nach Nierentransplantation.Med Klin 1987; 82:171–177.

    PubMed  Google Scholar 

  30. Eliahou HE, Cohen D, Ben-Davis A,et al. The calcium channel blocker nisoldipine delays progression of chronic renal failure in man (preliminary communication).Cardiovasc Drugs Ther 1988; 1:523–528.

    PubMed  Google Scholar 

  31. Krebs R. Calcium-antagonists. New vistas in theoretical basis and use of calcium-antagonists. In: Opie LH, ed.Calcium Antagonists and Cardiovascular Diseases. New York: Raven Press, 1984; 347–357.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bayer Italia S.P.A., Viale Certose 126, 20156, Milan, Italy

    Rolf Krebs

Authors
  1. Rolf Krebs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krebs, R. Calcium antagonists—Future uses. Cardiovasc Drug Ther 1, 613–616 (1988). https://doi.org/10.1007/BF02125747

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02125747

Key words

Search

Navigation